RVMD Stock Revolution Medicines, Inc.
US · NasdaqGSLast in our picks 2026-10-21 — not in the current list; analysis below is from that screen
Promising oncology launch and pipeline optionality offer significant forward value despite recent pullback.
Future value: $257.84 (+31.18%) · 6-12 months · analyst consensus
Signal breakdown
- ▸RBC sees physician enthusiasm and durable launch potential.
- ▾Below 50-day MA (-2.92%)
- ▸Above 200-day MA — long-term uptrend
- ▸Near 52-week high (83.8% of range) — strength
- ▸~31% upside to price target
Is RVMD a buy right now?
Trend: RVMD is trading below the 50-day average (-7.23%), RSI 60 — neutral momentum, with a 3-month return of -0.57%.
Valuation & quality: Revolution Medicines, Inc. trades on forward P/E -31.9, price-to-book 15.12; fundamentals show net margin 0.0%, return on equity -79.1%.
Analyst consensus: 24 analysts have a mean 12-month price target of $258.84 (+40.8% vs the last close; range $179.00 – $320.00), consensus rating “strong buy”.
Our screen: STRONG BUY (score 5) — Promising oncology launch and pipeline optionality offer significant forward value despite recent pullback.
Computed from end-of-day data; not personal advice.
Our track record with RVMD
Our simulated $10,000 funds have traded RVMD 1 time — 0 of 1 closed trade profitable.
| Fund | Bought | Sold | Return |
|---|---|---|---|
| US High-risk | 2026-09-22 @ $199.28 | 2026-10-09 @ $188.12 · AI review sell | -5.60% |
Paper trades from our simulated funds at real end-of-day prices; past results don't predict future returns.
12-month price chart
Monthly returns
| Mar 26 | Apr 26 | May 26 | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|---|---|
| -4.70% | +48.20% | +9.30% | +18.90% | +0.10% | +9.60% | -0.20% | -8.90% |
Fundamentals
Analyst price target
Technical signals
About Revolution Medicines, Inc.
Revolution Medicines, Inc., a clinical-stage precision oncology company, develops novel targeted therapies for RAS-addicted cancers.
Sector: Healthcare · Industry: Biotechnology · United States · 883 employees · Website
Related Health Care picks
Browse: all US stocks · Health Care picks · today's movers
Market data from end-of-day feeds; AI-generated research for educational purposes only — not investment advice.